A Comparative Analysis of Physiologically Based Pharmacokinetic Models for Human Immunodeficiency Virus and Tuberculosis Infections

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacokinetics 100%
• Human Immunodeficiency Virus Infection 100%
• Tuberculosis 100%
• Drug-Drug Interaction 33%
• Lopinavir 33%
• Rifampicin 33%
• Drug Development 16%
• Ritonavir 16%
• Lopinavir Plus Ritonavir 16%

Keyphrases

• Physiologically-based Pharmacokinetic Model 100%
• Tuberculosis Infection 100%
• Exposure Process 25%
• Regulatory Science 25%
• Biotransformation Process 25%
• Drug Regulatory 25%
• Performance Benchmark 25%
• Anti-TB 25%